543 related articles for article (PubMed ID: 27721278)
1. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
3. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
4. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
5. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes.
Tewari S; Misra V; Kumar V; Mishra RR; Yadav K; Paridhi ; Sangma H
Indian J Pathol Microbiol; 2022; 65(3):610-616. PubMed ID: 35900489
[TBL] [Abstract][Full Text] [Related]
7. The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer.
Koç N; Ayas S; Uygur L
Gynecol Oncol; 2014 Sep; 134(3):486-91. PubMed ID: 25038287
[TBL] [Abstract][Full Text] [Related]
8. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.
Horn LC; Kafkova S; Leonhardt K; Kellner C; Einenkel J
Int J Gynecol Pathol; 2013 Jul; 32(4):339-44. PubMed ID: 23722505
[TBL] [Abstract][Full Text] [Related]
9. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?
Roh MH; Kindelberger D; Crum CP
Am J Surg Pathol; 2009 Mar; 33(3):376-83. PubMed ID: 19011565
[TBL] [Abstract][Full Text] [Related]
10. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
[TBL] [Abstract][Full Text] [Related]
11. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
[TBL] [Abstract][Full Text] [Related]
12. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
Seidman JD
Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
[TBL] [Abstract][Full Text] [Related]
14. Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
Malmberg K; Klynning C; Flöter-Rådestad A; Carlson JW
Virchows Arch; 2016 Jun; 468(6):707-13. PubMed ID: 27003156
[TBL] [Abstract][Full Text] [Related]
15. [Fallopian tube: the dark face of pelvic carcinogenesis].
Watkin E; Devouassoux-Shisheboran M
Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240
[TBL] [Abstract][Full Text] [Related]
16. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases.
Tang S; Onuma K; Deb P; Wang E; Lytwyn A; Sur M; Daya D
Int J Gynecol Pathol; 2012 Mar; 31(2):103-10. PubMed ID: 22317864
[TBL] [Abstract][Full Text] [Related]
17. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
18. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Cass I; Walts AE; Barbuto D; Lester J; Karlan B
Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
Gao FF; Bhargava R; Yang H; Li Z; Zhao C
Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279
[TBL] [Abstract][Full Text] [Related]
20. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]